ZielBio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2010-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.itihealth.com
Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors
Phase 1
Completed
- Conditions
- Solid Tumor, AdultBiliary Cancer MetastaticOvarian Serous AdenocarcinomaOvarian Serous CystadenocarcinomaPancreatic Ductal; Adenocarcinoma
- Interventions
- First Posted Date
- 2021-10-12
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- ZielBio, Inc.
- Target Recruit Count
- 35
- Registration Number
- NCT05074472
- Locations
- 🇺🇸
Mayo Clinic - Phoenix, Phoenix, Arizona, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
🇺🇸Mayo Clinic - Rochester, Rochester, Minnesota, United States
News
No news found